International audienceThe neurotensin (NT) receptor-3 (NTSR3), also called sortilin is a multifunctional protein localized at the intracellular and plasma membrane level. The extracellular domain of NTSR3 (sNTSR3) is released by shedding from several cell lines including colonic cancer cells. This soluble protein acts as an active ligand through its ability to bind, to be internalized in the human adenocarcinoma epithelial HT29 cells and to stimulate the PI3 kinase pathway. The aim of this study was to investigate cellular responses induced by sNTSR3 in HT29 cells. The cellular functions of sNTSR3 were monitored by immunofluocytochemistry, electron microscopy and quantitative PCR in order to characterize the cell shape and the expression of...
In this study, we have investigated the involvement of the internalization process induced by neurot...
Background Neurotensin, originally isolated in 1973 has both endocrine and neuromodulator activity a...
Pancreatic cancer is one of the cancers with the poorest prognosis, with a 5‐year survival rate of a...
International audienceThe neurotensin (NT) receptor-3 (NTSR3), also called sortilin, is thought to d...
The aim of the present review is to unravel the mechanisms of action of the soluble form of the neur...
The purpose of this review is to decipher the mechanisms of the pathways leading to the complex role...
Neurotensin (NTS), a 13–amino acid peptide which is distributed predominantly along gastrointestinal...
BACKGROUND: While the neurotensin (NT) roles in pancreatic cancer growth are well documented, its ef...
AbstractWe recently reported the molecular identification of a new type of receptor for the neuropep...
The neurotensin receptor-3 also known as sortilin was the first member of the small family of vacuol...
Background: While the neurotensin (NT) roles in pancreatic cancer growth are well documented, its ef...
Neurotensin is a thirteen amino acid peptide that is found both in the central and peripheral nervou...
The neurotensin (NTS) and its specific high affinity G protein coupled receptor, the NT1 receptor (N...
International audience: The transfer of exosomes containing both genetic and protein materials is ne...
International audienceEmerging evidence supports neurotensin as a trophic and antiapoptotic factor, ...
In this study, we have investigated the involvement of the internalization process induced by neurot...
Background Neurotensin, originally isolated in 1973 has both endocrine and neuromodulator activity a...
Pancreatic cancer is one of the cancers with the poorest prognosis, with a 5‐year survival rate of a...
International audienceThe neurotensin (NT) receptor-3 (NTSR3), also called sortilin, is thought to d...
The aim of the present review is to unravel the mechanisms of action of the soluble form of the neur...
The purpose of this review is to decipher the mechanisms of the pathways leading to the complex role...
Neurotensin (NTS), a 13–amino acid peptide which is distributed predominantly along gastrointestinal...
BACKGROUND: While the neurotensin (NT) roles in pancreatic cancer growth are well documented, its ef...
AbstractWe recently reported the molecular identification of a new type of receptor for the neuropep...
The neurotensin receptor-3 also known as sortilin was the first member of the small family of vacuol...
Background: While the neurotensin (NT) roles in pancreatic cancer growth are well documented, its ef...
Neurotensin is a thirteen amino acid peptide that is found both in the central and peripheral nervou...
The neurotensin (NTS) and its specific high affinity G protein coupled receptor, the NT1 receptor (N...
International audience: The transfer of exosomes containing both genetic and protein materials is ne...
International audienceEmerging evidence supports neurotensin as a trophic and antiapoptotic factor, ...
In this study, we have investigated the involvement of the internalization process induced by neurot...
Background Neurotensin, originally isolated in 1973 has both endocrine and neuromodulator activity a...
Pancreatic cancer is one of the cancers with the poorest prognosis, with a 5‐year survival rate of a...